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Abstract. Two simple, fast, accurate and precise meth-
ods for the determination of six phenothiazines and
a number of their pharmaceutical formulations are
described. The titrimetric method involves the oxidation
of the drugs by metavanadate in sulphuric acid medium
and titration of vanadium(IV) formed, with cerium(IV)
using ferroin indicator and acetone as catalyst. In spec-
trophotometry, vanadium(IV) formed was reacted with
ferriin and the resulting ferroin measured at 510 nm.
Phenothiazines in the ranges 5–100 mg and 2.5–
25.0mg mLÿ1 can be determined by titrimetry and
spectrophotometry, respectively, with detection limits
of 0.96–2.05 mg and 0.0359–0.0565mg mLÿ1, respec-
tively. Both methods were applied successfully to the
determination of the studied drugs in pharmaceutical
preparations. The reliability of the assays was estab-
lished by parallel determination by the official methods
of British Pharmacopoeia and the results being statis-
tically evaluated.
Key words: Phenothiazine determination; titrimetry; spectropho-
tometry; metavanadate; pharmaceutical formulations.
N-substituted phenothiazines such as chlorpromazine
hydrochloride (CPH), promethazine hydrochloride
(PH), trifluperazine hydrochloride (TFPH), thioridazine
hydrochloride (TH) prochlorperazine maleate (PCPM)
and prochlorperazine mesylate (PCPMS) are widely
used as psychotropic and antiallergic drugs. They also
possess antiemetic, sedative, antipruritic and analgesic
properties [1]. They have been officially determined by
titrimetry with glacial acetic acid solution of perchloric
acid or by UV-spectrophotometry [2]. Various methods
have been reported for the assay of phenothiazines.
Titrations with hexacyanoferrate(III) [3], chloramine-
T [4], N-bromosuccinimide [5], iodate [6], dichromate
[7], lead picrate [8] and bismuth nitrate [9] have been
proposed. But the methods using hexacyanoferrate(III),
chloramine-T and dichromate involve the use of very
high acid concentrations and in the NBS method the
reaction stoichiometry changes with contact time. The
use of lead picrate and bismuth nitrate involves
the filtration of the precipitate formed before titrating
the unreacted metal with EDTA.
Spectrophotometric methods based on diazotization
and coupling with arylamine [10], charge-transfer
complex formation [11], ion-association complex for-
mation [12], ternary complex formation [13] or through
formation of the Schiff base with p-dimethylamino-
benzaldehyde [14] have also been reported. A common
method of general applicability involves the forma-
tion of purple-red or orange-red radical cations
when phenothiazines are oxidized by oxidants like N-
bromosuccinimide [15], chloramine-T [16], sodium
cobalt(III)nitrite [17], hexacyanoferrate(III) [18], potas-
sium periodate [19] or cerium(IV) sulphate [20] and
subsequent measurement of the colour. In this method,
the amounts of acid and oxidant used are critical. One
of the present authors has earlier reported the titrimetric
[21] and spectrophotometric [22] determination of
some phenothiazines employing metavanadate as the
reagent, but the titrimetric procedure employs a very
high acid concentration (5 ml each of 10 M-H2SO4 and
10 M-H3PO4 in a total volume of 15 ml) whereas in the
spectrophotometric procedure the working conditions
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are critical and the coloured species is stable for only
15 min. An indirect spectrophotometric method [23]
employing metavanadate proposed earlier, requires
heating and lacks sensitivity (range 50–1000mg mLÿ1).
The present work aims to demonstrate the utility of
metavanadate for the indirect determination of some
phenothiazines by titrimetric and spectrophotometric
methods which overcome some of the drawbacks in the
methods reported earlier.
Experimental
Appartus
Absorbance measurements were made using a 106 Systronics digital
spectrophotometer with quartz cells of 10 mm pathlength.
Materials and Reagents
Analytical reagent grade chemicals and doubly distilled water
were used throughout. Cerium(IV) sulphate (approx. 0.05 M) was
prepared by dissolving 20 g of sample in 1 M-H2SO4 and diluting to
one litre with the same acid. It was standardised by the iron(II)
ammonium sulphate method [24]. Sodium metavanadate (approx.
0.05 M) was prepared by dissolving 6 g reagent in water and diluted
to one litre. Ferriin reagent was prepared by mixing 0.198 g of 1,10-
phenanthroline monohydrate, 2 ml of 1 M hydrochloric acid and
0.16 g of iron(III) ammonium sulphate and diluting to 100 ml with
water. Ferroin indicator was prepared by dissolving 1.485 g of the
base in 100 ml of water containing 0.695 g of ferrous sulphate
heptahydrate. Sulphuric acid (10 M), acetic acid (10 M), ammonia
(1:1) were prepared using analytical-grade reagent chemicals.
Standard Solutions of Phenothiazines
Pure drug samples were kindly provided by several pharmaceutical
companies and used as received. Dosage forms containing the com-
pounds were purchased from commercial sources. Stock standard
solutions containing 5 mg mLÿ1 drug were prepared by dissolving
weighed amounts of CPH (British Pharm), PH (Rhone Poulenc),
TFPH (SmithKline Beecham), TH (Sandoz) PCPM and PCPMS
(Rhone-Poulenc) in water. In respect of PCPM, a few drops of dil.
hydrochloric acid were used for better dissolution. The solutions
were kept in amber coloured bottles and stored in a refrigerator.
For spectrophotometric work, the stock solutions were diluted to
100mg mLÿ1 of drug in water.
Analytical Procedures
Titrimetry. A 10 or 15 mL aliquot of drug solution containing 10–
75 mg CPH, 5–75 mg PH, 5–50 mg TH, 10–100 mg TFPH, PCPM
or PCPMS was transferred into a 100 mL conical flask and 3 mL
of 10 M sulphuric acid were added followed by 10 mL of 0.05 M
vanadate solution. The reaction mixture was shaken occassionally
and after a specified time (Table 1), the vanadium(IV) formed was
titrated with standardised cerium(IV) sulphate solution (0.05 M)
using two drops of ferroin as indicator, and 10 mL acetone. From the
volume of cerium(IV) sulphate consumed, the amount of the drug
was calculated.
Spectrophotometry. Different aliquots, i.e., 0–2.0 mL of CPH,
0–1.75 mL of PH, 0–2.5 mL of TH, 0–2.25 mL of TFPH, 0–3.0 mL
of PCPM or 0–2.5 mL of PCPMS (each 100mg mLÿ1) were
transferred into 10 mL standard flasks. 0.5 mL of 10 M-H2SO4 were
added to each flask followed by 0.5 mL of 0.05 M-vanadate solution.
The total volume was adjusted to 4 mL by adding water. The
contents were mixed well and let stand for specified time (Table 2)
for the oxidation of the drugs to complete as indicated by the
disappearance of the purple-red, red, orange-red or blue colour of
the radical cation. Then, 2 mL of 10 M-acetic acid and 2 mL of
ferriin reagent were added and after 5 min, 2 mL of 1:1 ammonia
were added and diluted to 10 mL with water, mixed well and the
absorbance of the coloured solution measured at 510 nm against the
reagent blank after 10 min. The amount of drugs was deduced from
the standard calibration plots or regression equations.
Procedure for Pharmaceutical Preparations
Tablets. Twenty to one hundred tablets depending on content
per tablet were weighed and ground. An amount of the powder
equivalent to 500 mg of the active component was weighed into a
100 mL volumetric flask, about 50 mL of water were added and
shaken thoroughly for about 15 min. The volume was made up to the
mark with water, mixed well and filtered using a quantitative filter
paper. A suitable aliquot was analysed by titrimetry. The filtrate was
diluted stepwise to get 100mg mLÿ1 solution of each drug and used
for analysis by spectrophotometry. In respect of PCPM tablets a few
drops of 1.0 M-HCl were used to aid extraction of the active
component.
Injections. The contents of twenty ampoules were mixed and an
accurately measured volume equivalent to 500 mg of drug was
Table 1. Analytical data for the titrimetric determination of phenothiazines
Drug Reaction time, Range, LOD, LOQ, Correlation,
min mg mg mg coefficient,
r
CPH 10 10–75 1.01 3.38 0.9711
PH 10 5–75 0.96 3.21 0.9975
TH 5 5–50 1.23 4.11 0.9999
TFPH 20 10–100 1.44 4.82 0.9999
PCPM 20 10–100 1.90 6.04 0.9991
PCPMS 15 10–100 2.05 6.84 0.9999
LOD Limit of detection; LOQ Limit of quantification.
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transferred into a 100 mL volumetric flask and diluted to the mark
with water. The solution was then treated as described under tablets.
Results and Discussion
Titrimetry. Of the few titrimetric procedures [25–28]
available for determination of vanadium(IV), the most
convenient and simple method is the titration of
vanadium(IV) in acidic solution with cerium(IV)
sulphate using ferroin as the indicator and acetone as
the catalyst [28]. The proposed titrimetric procedure for
the determination of phenothiazines is based on the
oxidation of the drugs first to coloured phenothiazi-
nium-free radicals and finally to the colourless
sulphoxides [29, 30] by vanadate in acid medium and
the titration of the resulting vanadium(IV) with
cerium(IV) sulphate as described by Sriramam et al.
[28]. For the oxidation of the drugs as well as the
titration of vanadium(IV) an overall H2SO4 concentra-
tion of 2–2.5 M was found adequate.
All the six drugs investigated were found to react
with vanadate in the ratio 1:2 which is in agreement
with that reported earlier [21]. The relationship
Table 2. Optical characteristics for the spectrophotometric determination of phenothiazines
Characteristics CPH PH TH TFPH PCPM PCPMS
Reaction time (min) 15 5 5 20 10 15
Beer’s law limits 2.5–20 2.5–17.5 2.5–25 2.5–22.5 2.5–30 2.5–25
(mg mLÿ1)
Detection limit 0.0565 0.0501 0.0359 0.0396 0.0514 0.0527
(mg mLÿ1)
Molar absorptivitiy 1:00 104 1:02 104 1:87 104 2:02 104 2:00 104 2:09 104
1 molÿ1 cmÿ1)
Sandell sensitivity 3.52 3.14 2.18 2.39 3.04 3.27
(ng cmÿ1)
Regression
equation Y
Intercept (a) ÿ0.0026 ÿ0.0076 0.0064 0.0085 0.0088 ÿ0.0046
Slope (b) 0.0288 0.0325 0.0453 0.0409 0.0316 0.0308
Correlation 0.9990 0.9997 0.9998 0.9998 0.9994 0.9998
coefficient (r)
 y abx where ‘y’ is the absorbance for concentration ‘x’ in mg mLÿ1.
Table 3. Evaluation of accuracy and precision of the proposed methods
Drug Titrimetric method Spectrophotometric method
Amount Amount RSD, % Amount Amount RSD, %
taken, found, taken, mg found, mg
mg mg
CPH 10 9.85 0.44 30 30.21 0.26
30 29.67 0.76 100 102.67 0.33
60 61.44 0.82 200 198.06 0.21
PH 5 4.94 1.26 30 30.42 0.44
30 30.45 0.65 90 91.69 0.72
60 60.66 1.04 160 158.22 0.64
TH 5 4.89 0.96 50 48.67 1.18
20 19.80 0.34 150 148.05 0.39
40 40.80 0.92 200 198.34 0.86
TFPH 10 10.15 0.63 40 40.96 0.52
50 49.86 0.76 150 149.37 0.22
80 81.88 0.26 200 201.30 0.36
PCPM 10 10.14 1.13 60 60.22 0.62
50 50.75 0.54 200 203.42 0.18
80 80.74 0.37 280 285.06 0.49
PCPMS 10 9.95 0.84 50 49.60 0.37
50 50.17 0.62 150 149.08 0.60
80 79.06 0.38 200 196.50 0.78
 Average of seven determinations. RSD Relative standard deviation.
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between the titration end-point and the drug amount
was also examined. The linearity between the amount
of the drug and titration end-point is apparent from the
correlation coefficient, r (0.9711–0.9999), obtained
by the best fit line via linear least squares treatment.
The calculated values of r show that the reaction
between the drugs and the vanadate proceeds stoichio-
metrically in the ratio 1:2.
Spectrophotometry. One of the sensitive spectrophoto-
metric methods reported for vanadium(IV) involves the
reduction of ferriin by vanadium(IV) to orange-red
ferroin and its measurement at 510 nm [31]. In this
work, excessive vanadium(V) was used to oxidise
phenothiazines in sulphuric acid medium to colourless
sulphoxides and the vanadium(IV) formed was deter-
mined by reacting it with ferriin in H2SO4-CH3COOH
medium and later raising the pH favourable for the
formation of ferroin. Phenothiazines, when added in
increasing amounts, consume vanadium(V); conse-
quently there is a concomitant rise in vanadium(IV)
concentration. This is observed as a proportional
increase in the absorbance of the reaction product on
increasing the concentration of phenothiazines.
The various parameters involved in this study were
optimised. Since the reaction: Fe Phen33  VIV 
Fe Phen23  VV is favourable in presence of
0.67 M-H2SO4 and 2.5 M-CH3COOH, 0.5 mL of 10 M-
H2SO4 and 2 mL of 10 M CH3COOH and 2 mL of
ferriin reagent were used to force the reaction to go to
completion. A 0.5 mL volume of 10 M-H2SO4 in a total
volume of 4 mL was found adequate for the oxidation
of the drugs to their respective sulphoxides in a reason-
able time of 5–20 min depending on the individual
phenothiazine derivative. Since ferroin is formed in the
pH range of 2–9, the pH of acidic medium employed for
the redox reaction between vanadium(IV) and ferriin
was raised by adding 2 mL of 1:1 ammonia solution
which was found to be optimum. The full colour
was developed in 10 min and was stable for several
months.
Analytical Data. The reaction times, detection limits,
molar absorptivities and Sandell sensitivities are given
in Table 2. The slope and intercept values obtained by
using linear least squares treatment of the results of the
systems are also presented in Table 2. The correlation
coefficients of the calibration plots are in the range
0.9990–0.9998 confirming a linear increase in absorb-
ance with increasing concentration of drugs.
To examine the validity and the applicability of the
proposed methods and the reproducibility of the results,
seven replicate determinations at different concentra-
tions of drugs were performed. The relative standard
deviations were less than 2% (Table 3) which indicate
the high precision of the methods.
The methods were applied to the assay of the studied
drugs in tablets and injections. The results obtained
were found to be in good agreement with those of the
official methods. The calculated t- and F-values did not
exceed the theoretical values indicating no significant
difference between the proposed methods and official
methods [1].
In pharmaceutical analysis, it is important to test the
selectivity towards the excipients and fillers added to
the pharmaceutical formulations. Fortunately, such
materials mostly do not interfere. This is clear from
the results obtained for the pharmaceutical preparations
(Table 4) that the excipients do not interfere.
The proposed procedures for the determination of
phenothiazines in pure form and in pharmaceutical
formulations are simple and exhibit a fair degree of
accuracy and precision. They are applicable over a
wide dynamic concentration range, contrary to most
of the reported direct methods. The spectrophoto-
metric method is one of the highly sensitive methods
ever reported for phenothiazines. The method is free
from the usual analytical complications like heating,
extraction, critical acid or reagent concentration
and instability of the coloured species. These advant-
ages make both methods suitable for the routine
analysis of the pure drugs and their pharmaceutical
formulations.
References
[1] M. Gordon (Ed.) Psychopharmacological Agents, Vol. II
Academic Press, New York, 1964.
[2] The British Pharmacopoeia, Her Majesty’s Stationery Office,
London, 1995.
[3] A. S. Issa, M. S. Mahrous, Talanta 1984, 31, 287.
[4] A. N. Nayak, Rangaswamy, H. S. Yathirajan, P. G. Ramappa,
Indian Drugs 1982, 19, 202.
[5] M. I. Walash, R. Mohamed, A. M. Abou-Ouf, F. Belal, Analyst
(London) 1983, 108, 626.
[6] K. Basavaiah, J. Manjunatha Swamy, Oxidation Commun.
2000, 23, 212.
[7] K. Basavaiah, G. Krishnamurthy, Anal. Sci. 1999, 15, 67.
[8] M. Gajewska, Chem. Anal. (Warsaw) 1973, 18, 651.
[9] M. Basinska, H. Puzanowska-Tarasiewicz, M. Tarasiewicz,
Acta Pol. Pharm. 1970, 27, 123.
[10] S. R. El-Shabouri, Talanta 1985, 32, 995.
[11] M. Abdel-Salam, A. S. Issa, M. S. Mahrous, M. S. Abdel-
Hameed, Anal. Lett. 1985, 18, 1391.
Titrimetric and Spectrophotometric Determination of Some Phenothiazine Psychotropics in Pure Form 79
[12] K. Basavaiah, J. Manjunatha Swamy, G. Krishnamurthy,
Chem. Anal. (Warsaw) 1999, 44, 1049.
[13] Y. Fujitha, I. Mori, K. Fujta, Y. Nakahashi, J. Janaka, Chem.
Pharm. Bull. 1987, 35, 5004.
[14] T. P. Gandhi, M. R. Patel, A. A. Patel, V. C. Patel, Indian Drugs
1979, 16, 242.
[15] A. M. Taha, N. A. El-Rabbat, M. E. El-Kommos, I. H. Refat,
Analyst (London) 1983, 108, 1500.
[16] H. Puzanowska-Tarasiewicz, A. Kojlo, Farm. Pol. 1983, 39,
141.
[17] M. S. Mahrous, M. Abdel-Khalek, Talanta 1984, 31, 285.
[18] K. Basavaiah, G. Krishnamurthy, Ann. Chim. (Rome) 1999,
89(7–8), 623.
[19] K. Basavaiah, Srilatha, J. Manjunatha Swamy, Anal. Lett.
2000, 33, 43.
[20] W. Stisinik, M. Tarasiewicz, Pharmazie 1996, 51, 62.
[21] K. Basavaiah, G. Krishnamurthy, Mikrochim. Acta 1999, 130,
197.
[22] K. Basavaiah, P. G. Ramappa, Eastern Pharm. 1984, 27, 131.
[23] S. Singh, I. C. Shukla, S. Shukla, Indian J. Pharm Sci. 1988,
50, 278.
[24] I. M. Kolthoff, R. Belcher, V. A. Stenger, G. Matsuyama,
Volumetric Analysis, 1957, Vol. III. Interscience Publishers,
New York.
[25] N. Venkateswara Rao, V. V. S. Eswara Dutt, Anal. Chim. Acta
1970, 51, 553.
[26] M. Zaky, W. G. Hanna, Microchem. J. 1986, 34, 235.
[27] S. A. Chimatadav, S. T. Nandibewoor, T. R. Raju, J. Indian
Chem. Soc. 1989, 66, 919.
[28] K. Sriramam, B. S. R. Sarma, B. S. Sundar, N. R. Sastry,
Talanta 1981, 28, 287.
[29] G. Dusinsky, O. Liskova, Chem. Zvestii 1958, 12, 213.
[30] W. G. Belikov, G. F. Moiseeva, Farmatsiya (Moscow) 1986,
36, 87.
[31] G. N. Rao, Ravi Prakash, Curr. Sci. 1974, 43, 279.
Received September 26, 2000. Revision March 25, 2001.
80 Titrimetric and Spectrophotometric Determination of Some Phenothiazine Psychotropics in Pure Form
